Renovia Inc., a leading company in the field of developing digital therapeutics for female pelvic floor disorders informed that Leva, a pelvic health system to treat women in urinary continence received acceptance from researchers supporting its value. It is stated that Leva can provide UI symptom improvement for 12 months and creates real-world data to increase its effectiveness.
Boston Scientific Corporation declared that Solyx, a single incision sling system succeeded in the treatment of women with stress urinary incontinence. It is designed to decrease dissection and provide a less complicated procedure.
Author Credits: Radhika Gupta, Shivam Bhutani